Clinical Trial Update: Hypoxia Driven Metabolic Response in Oesophagogastric Adenocarcinoma

View source ↗

Summary

A clinical trial exploring hypoxia-driven metabolic response in esophagogastric adenocarcinoma is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophagogastric Adenocarcinoma

Snippet

Sponsor: Imperial College London | Conditions: OESOPHAGO-GASTRIC CARCINOMA | Status: RECRUITING